Literature DB >> 22909050

Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP.

Suvi-Tuuli Vilen1, Juho Suojanen, Fidel Salas, Juha Risteli, Merja Ylipalosaari, Outi Itkonen, Hannu Koistinen, Marc Baumann, Ulf-Håkan Stenman, Timo Sorsa, Tuula Salo, Pia Nyberg.   

Abstract

Enhanced proteolysis and altered tight junction (TJ) proteins associate with carcinoma invasion. We hypothesized that trypsin-2, a tumor-associated serine proteinase, induces tongue carcinoma invasion by activating pro-membrane type-1 matrix metalloproteinase (MT1-MMP) and disturbing the TJs. The effects of invasion were analyzed using trypsin-2 over-expressing human tongue squamous cell carcinoma cells (Try2-HSC-3) in vitro and in vivo. The invasion of Try2-HSC-3 cells was increased in mouse xenografts and human organotypic model. Trypsin-2 activated proMT1-MMP, as well as altered the expression of TJ protein claudin-7. In conclusion, trypsin-2 over-expression enhanced tongue carcinoma cell invasion by various genetic and proteolytic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22909050     DOI: 10.3109/07357907.2012.716467

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

1.  Collagen degradation by tumor-associated trypsins.

Authors:  Lynn S Mirigian; Elena Makareeva; Hannu Koistinen; Outi Itkonen; Timo Sorsa; Ulf-Håkan Stenman; Tuula Salo; Sergey Leikin
Journal:  Arch Biochem Biophys       Date:  2013-03-28       Impact factor: 4.013

2.  Design of modular dual enzyme-responsive peptides.

Authors:  Natalie Boehnke; Heather D Maynard
Journal:  Biopolymers       Date:  2017-08-11       Impact factor: 2.240

3.  Tissue matrix arrays for high-throughput screening and systems analysis of cell function.

Authors:  Vince Z Beachley; Matthew T Wolf; Kaitlyn Sadtler; Srikanth S Manda; Heather Jacobs; Michael R Blatchley; Joel S Bader; Akhilesh Pandey; Drew Pardoll; Jennifer H Elisseeff
Journal:  Nat Methods       Date:  2015-10-19       Impact factor: 28.547

4.  Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis.

Authors:  Katherine Falkowski; Ewa Bielecka; Ida B Thøgersen; Oliwia Bocheńska; Karolina Płaza; Magdalena Kalińska; Laura Sąsiadek; Małgorzata Magoch; Aleksandra Pęcak; Magdalena Wiśniewska; Natalia Gruba; Magdalena Wysocka; Anna Wojtysiak; Magdalena Brzezińska-Bodal; Kamila Sychowska; Anastasija Pejkovska; Maren Rehders; Georgina Butler; Christopher M Overall; Klaudia Brix; Grzegorz Dubin; Adam Lesner; Andrzej Kozik; Jan J Enghild; Jan Potempa; Tomasz Kantyka
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 5.  Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma.

Authors:  Suvi-Tuuli Vilen; Tuula Salo; Timo Sorsa; Pia Nyberg
Journal:  ScientificWorldJournal       Date:  2013-01-08

6.  The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC).

Authors:  F Hakami; L Darda; P Stafford; P Woll; D W Lambert; K D Hunter
Journal:  Br J Cancer       Date:  2014-07-10       Impact factor: 7.640

7.  Palmitoylated claudin7 captured in glycolipid-enriched membrane microdomains promotes metastasis via associated transmembrane and cytosolic molecules.

Authors:  Florian Thuma; Sarah Heiler; Martina Schnölzer; Margot Zöller
Journal:  Oncotarget       Date:  2016-05-24

Review 8.  Organotypic three-dimensional assays based on human leiomyoma-derived matrices.

Authors:  Tuula Salo; Mauricio Rocha Dourado; Elias Sundquist; Ehsanul Hoque Apu; Ilkka Alahuhta; Katja Tuomainen; Jenni Vasara; Ahmed Al-Samadi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 9.  Is There a Trojan Horse to Aggressive Pancreatic Cancer Biology? A Review of the Trypsin-PAR2 Axis to Proliferation, Early Invasion, and Metastasis.

Authors:  Kjetil Søreide; Marcus Roalsø; Jan Rune Aunan
Journal:  J Pancreat Cancer       Date:  2020-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.